| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | DBeQ | CTRPv2 | pan-cancer | AAC | -0.0094 | 0.8 |
| mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0089 | 0.8 |
| mRNA | tubastatin A | CTRPv2 | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | 0.015 | 0.8 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | -0.0091 | 0.8 |
| mRNA | QL-XII-61 | GDSC1000 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | -0.0096 | 0.8 |
| mRNA | CGP-60474 | GDSC1000 | pan-cancer | AAC | -0.014 | 0.8 |
| mRNA | ETP-46464 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | 0.0089 | 0.8 |